Literature DB >> 18414996

Decylubiquinol impedes mitochondrial respiratory chain complex I activity.

Paule Bénit1, Abdelhamid Slama, Pierre Rustin.   

Abstract

We have studied the interaction of decylubiquinone, an effective substrate for respiratory chain complexes III and II, with complex I in mouse and human tissues. We found that its reduced form, decylubiquinol, severely impedes complex I activity, while the oxidized form, decylubiquinone acts as a potent acceptor for complex I electrons. This observation has obvious incidence on the assay conditions for complex I. In keeping with that, we found that the inhibition by the reduced form can be avoided by maintaining decylubiquinone under an oxidized form. Under these experimental conditions, a high complex I activity could be measured allowing to detect partial complex I deficiency. Use of these conditions is however restricted to tissues/cells with limited contaminating NADH dehydrogenase activities that are prone to react with redox active compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414996     DOI: 10.1007/s11010-008-9763-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Kinetic microplate-based assays for inhibitors of mitochondrial NADH:ubiquinone oxidoreductase (complex I) and succinate:cytochrome c oxidoreductase.

Authors:  P J Jewess; A L Devonshire
Journal:  Anal Biochem       Date:  1999-07-15       Impact factor: 3.365

Review 2.  Structural organization of the mitochondrial respiratory chain.

Authors:  Maria Luisa Genova; Cristina Bianchi; Giorgio Lenaz
Journal:  Ital J Biochem       Date:  2003-03

3.  Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples.

Authors:  Paule Bénit; Sergio Goncalves; Emmanuel Philippe Dassa; Jean-Jacques Brière; Gail Martin; Pierre Rustin
Journal:  Clin Chim Acta       Date:  2006-06-02       Impact factor: 3.786

4.  Effect of endogenous ubiquinone on the reduction and oxidation of short exogenous ubiquinone homologs in beef heart mitochondria.

Authors:  L Landi; P Pasquali; L Cabrini; G Lenaz
Journal:  Boll Soc Ital Biol Sper       Date:  1979-10-30

5.  Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia.

Authors:  Nicholas A Di Prospero; Charlotte J Sumner; Scott R Penzak; Bernard Ravina; Kenneth H Fischbeck; J Paul Taylor
Journal:  Arch Neurol       Date:  2007-06

Review 6.  Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.

Authors:  Vanna Geromel; Niklas Darin; Dominique Chrétien; Paule Bénit; Pascale DeLonlay; Agnès Rötig; Arnold Munnich; Pierre Rustin
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

7.  A simplified and reliable assay for complex I in human blood lymphocytes.

Authors:  L E A de Wit; L Spruijt; G C Schoonderwoerd; I F M de Coo; H J M Smeets; H R Scholte; W Sluiter
Journal:  J Immunol Methods       Date:  2007-08-01       Impact factor: 2.303

8.  Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase.

Authors:  Chwen-Lih Chen; Liwen Zhang; Alexander Yeh; Chun-An Chen; Kari B Green-Church; Jay L Zweier; Yeong-Renn Chen
Journal:  Biochemistry       Date:  2007-04-20       Impact factor: 3.162

Review 9.  Biochemical and molecular investigations in respiratory chain deficiencies.

Authors:  P Rustin; D Chretien; T Bourgeron; B Gérard; A Rötig; J M Saudubray; A Munnich
Journal:  Clin Chim Acta       Date:  1994-07       Impact factor: 3.786

10.  Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress.

Authors:  Boris V Chernyak; Denis S Izyumov; Konstantin G Lyamzaev; Alina A Pashkovskaya; Olga Y Pletjushkina; Yuri N Antonenko; Dmitrii V Sakharov; Karel W A Wirtz; Vladimir P Skulachev
Journal:  Biochim Biophys Acta       Date:  2006-04-07
View more
  5 in total

1.  The membrane subunit NuoL(ND5) is involved in the indirect proton pumping mechanism of Escherichia coli complex I.

Authors:  Eiko Nakamaru-Ogiso; Mou-Chieh Kao; Han Chen; Subhash C Sinha; Takao Yagi; Tomoko Ohnishi
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

2.  Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.

Authors:  Claire Angebault; Naïg Gueguen; Valérie Desquiret-Dumas; Arnaud Chevrollier; Virginie Guillet; Christophe Verny; Julien Cassereau; Marc Ferre; Dan Milea; Patrizia Amati-Bonneau; Dominique Bonneau; Vincent Procaccio; Pascal Reynier; Dominique Loiseau
Journal:  BMC Res Notes       Date:  2011-12-22

3.  Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies.

Authors:  Claire Angebault; Pierre-Olivier Guichet; Yasmina Talmat-Amar; Majida Charif; Sylvie Gerber; Lucas Fares-Taie; Naig Gueguen; François Halloy; David Moore; Patrizia Amati-Bonneau; Gael Manes; Maxime Hebrard; Béatrice Bocquet; Mélanie Quiles; Camille Piro-Mégy; Marisa Teigell; Cécile Delettre; Mireille Rossel; Isabelle Meunier; Markus Preising; Birgit Lorenz; Valerio Carelli; Patrick F Chinnery; Patrick Yu-Wai-Man; Josseline Kaplan; Agathe Roubertie; Abdelhamid Barakat; Dominique Bonneau; Pascal Reynier; Jean-Michel Rozet; Pascale Bomont; Christian P Hamel; Guy Lenaers
Journal:  Am J Hum Genet       Date:  2015-10-22       Impact factor: 11.025

4.  The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes.

Authors:  Paule Bénit; Sergio Goncalves; Emmanuel Philippe Dassa; Jean-Jacques Brière; Pierre Rustin
Journal:  PLoS One       Date:  2008-09-15       Impact factor: 3.240

5.  Isopropyl-phloroglucinol-DHA protects outer retinal cells against lethal dose of all-trans-retinal.

Authors:  Aurélie Cubizolle; David Cia; Espérance Moine; Nathalie Jacquemot; Laurent Guillou; Mélissa Rosell; Claire Angebault-Prouteau; Guy Lenaers; Isabelle Meunier; Joseph Vercauteren; Thierry Durand; Céline Crauste; Philippe Brabet
Journal:  J Cell Mol Med       Date:  2020-03-25       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.